SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-003887
Filing Date
2024-03-26
Accepted
2024-03-26 08:15:30
Documents
51
Period of Report
2024-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20240326x8k.htm   iXBRL 8-K 41243
2 EX-99.1 apre-20240326xex99d1.htm EX-99.1 139139
3 EX-99.2 apre-20240326xex99d2.htm EX-99.2 54458
4 GRAPHIC apre-20240326xex99d2g001.jpg GRAPHIC 106217
5 GRAPHIC apre-20240326xex99d2g002.jpg GRAPHIC 335203
6 GRAPHIC apre-20240326xex99d2g003.jpg GRAPHIC 176037
7 GRAPHIC apre-20240326xex99d2g004.jpg GRAPHIC 121133
8 GRAPHIC apre-20240326xex99d2g005.jpg GRAPHIC 146126
9 GRAPHIC apre-20240326xex99d2g006.jpg GRAPHIC 178396
10 GRAPHIC apre-20240326xex99d2g007.jpg GRAPHIC 56504
11 GRAPHIC apre-20240326xex99d2g008.jpg GRAPHIC 148623
12 GRAPHIC apre-20240326xex99d2g009.jpg GRAPHIC 175389
13 GRAPHIC apre-20240326xex99d2g010.jpg GRAPHIC 108642
14 GRAPHIC apre-20240326xex99d2g011.jpg GRAPHIC 141713
15 GRAPHIC apre-20240326xex99d2g012.jpg GRAPHIC 129277
16 GRAPHIC apre-20240326xex99d2g013.jpg GRAPHIC 118202
17 GRAPHIC apre-20240326xex99d2g014.jpg GRAPHIC 57412
18 GRAPHIC apre-20240326xex99d2g015.jpg GRAPHIC 175780
19 GRAPHIC apre-20240326xex99d2g016.jpg GRAPHIC 135950
20 GRAPHIC apre-20240326xex99d2g017.jpg GRAPHIC 143042
21 GRAPHIC apre-20240326xex99d2g018.jpg GRAPHIC 59097
22 GRAPHIC apre-20240326xex99d2g019.jpg GRAPHIC 179032
23 GRAPHIC apre-20240326xex99d2g020.jpg GRAPHIC 176656
24 GRAPHIC apre-20240326xex99d2g021.jpg GRAPHIC 141121
25 GRAPHIC apre-20240326xex99d2g022.jpg GRAPHIC 163781
26 GRAPHIC apre-20240326xex99d2g023.jpg GRAPHIC 58667
27 GRAPHIC apre-20240326xex99d2g024.jpg GRAPHIC 167571
28 GRAPHIC apre-20240326xex99d2g025.jpg GRAPHIC 91300
29 GRAPHIC apre-20240326xex99d2g026.jpg GRAPHIC 61173
30 GRAPHIC apre-20240326xex99d2g027.jpg GRAPHIC 125015
31 GRAPHIC apre-20240326xex99d2g028.jpg GRAPHIC 167247
32 GRAPHIC apre-20240326xex99d2g029.jpg GRAPHIC 140371
33 GRAPHIC apre-20240326xex99d2g030.jpg GRAPHIC 117197
34 GRAPHIC apre-20240326xex99d2g031.jpg GRAPHIC 135476
35 GRAPHIC apre-20240326xex99d2g032.jpg GRAPHIC 78699
36 GRAPHIC apre-20240326xex99d2g033.jpg GRAPHIC 161442
37 GRAPHIC apre-20240326xex99d2g034.jpg GRAPHIC 161529
38 GRAPHIC apre-20240326xex99d2g035.jpg GRAPHIC 152921
  Complete submission text file 0001558370-24-003887.txt   6998527

Data Files

Seq Description Document Type Size
39 EX-101.SCH apre-20240326.xsd EX-101.SCH 3997
40 EX-101.DEF apre-20240326_def.xml EX-101.DEF 2846
41 EX-101.LAB apre-20240326_lab.xml EX-101.LAB 17247
42 EX-101.PRE apre-20240326_pre.xml EX-101.PRE 11357
54 EXTRACTED XBRL INSTANCE DOCUMENT apre-20240326x8k_htm.xml XML 4859
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 24780987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)